Metraipolis › archive › dc_2ef42271195b

Efficacy and Safety of Statins in MASLD and Other Chronic Liver Diseases — Europe PMC PMID:41718130

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41718130
DOI
10.3390/medsci14010084
License (as archived)
solo-consultazione
Archived
2026-11-05T23:00:55.578Z
SHA-256 of the archived text
855f4291b9f51bc1256dd88bb212b13854a011a4b144986c83346ad34cf1ba74
Stable URL of this page
https://metraipolis.com/documento/dc_2ef42271195b

How to cite

Efficacy and Safety of Statins in MASLD and Other Chronic Liver Diseases — Europe PMC PMID:41718130 — Europe PMC (en), https://europepmc.org/article/MED/41718130 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2ef42271195b (Metraipolis archive dc_2ef42271195b, sha256 855f4291b9f51bc1256dd88bb212b13854a011a4b144986c83346ad34cf1ba74)
BibTeX
@misc{dc2ef42271195b,
  title = {Efficacy and Safety of Statins in MASLD and Other Chronic Liver Diseases — Europe PMC PMID:41718130},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41718130},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2ef42271195b; sha256 855f4291b9f51bc1256dd88bb212b13854a011a4b144986c83346ad34cf1ba74},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41718130. Agents can read the archived copy with the MCP tool read_document.